The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Pál Pacher

Corresponding author: Pál Pacher


Name/email consistency: high



  • Corresponding author: Pál Pacher. 2012
  • Section on Oxidative Stress Tissue Injury, Laboratory of Physiological Studies, National Institutes of Health/NIAAA, 5625 Fishers Lane, USA. 2007 - 2009
  • Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, USA. 2004 - 2008
  • National Institutes of Health, NIAAA, Laboratory of Physiological Studies, 5625 Fishers Lane MSC 9413, USA. 2005 - 2008
  • LPS, NIAAA, NIH, Bethesda, MD 20892-9413, USA. 2005
  • National Institute on Alcohol Abuse and Alcoholism, 12420 Parklawn Dr., MSC-8115, Bethesda, USA. 2004


  1. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Rajesh, M., Bátkai, S., Kechrid, M., Mukhopadhyay, P., Lee, W.S., Horváth, B., Holovac, E., Cinar, R., Liaudet, L., Mackie, K., Haskó, G., Pacher, P. Diabetes (2012) [Pubmed]
  2. The emerging role of the endocannabinoid system in cardiovascular disease. Pacher, P., Steffens, S. Semin. Immunopathol (2009) [Pubmed]
  3. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Pacher, P., Szabo, C. Am. J. Pathol. (2008) [Pubmed]
  4. Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Pacher, P., Haskó, G. Br. J. Pharmacol. (2008) [Pubmed]
  5. Poly(ADP-ribose) polymerase inhibition as a novel therapeutic approach against intraepidermal nerve fiber loss and neuropathic pain associated with advanced diabetic neuropathy: a commentary on "PARP Inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy". Pacher, P. Free Radic. Biol. Med. (2008) [Pubmed]
  6. Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases. Pacher, P., Gao, B. Am. J. Physiol. Gastrointest. Liver Physiol. (2008) [Pubmed]
  7. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Pacher, P., Nagayama, T., Mukhopadhyay, P., Bátkai, S., Kass, D.A. Nat. Protoc (2008) [Pubmed]
  8. Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. Pacher, P., Mukhopadhyay, P., Mohanraj, R., Godlewski, G., Bátkai, S., Kunos, G. Hypertension (2008) [Pubmed]
  9. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Pacher, P., Szabó, C. Cardiovasc. Drug. Rev (2007) [Pubmed]
  10. Nitric oxide and peroxynitrite in health and disease. Pacher, P., Beckman, J.S., Liaudet, L. Physiol. Rev. (2007) [Pubmed]
  11. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Pacher, P., Szabó, C. Curr. Opin. Pharmacol (2006) [Pubmed]
  12. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pacher, P., Nivorozhkin, A., Szabó, C. Pharmacol. Rev. (2006) [Pubmed]
  13. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase. Pacher, P., Bátkai, S., Osei-Hyiaman, D., Offertáler, L., Liu, J., Harvey-White, J., Brassai, A., Járai, Z., Cravatt, B.F., Kunos, G. Am. J. Physiol. Heart Circ. Physiol. (2005) [Pubmed]
  14. Blood pressure regulation by endocannabinoids and their receptors. Pacher, P., Bátkai, S., Kunos, G. Neuropharmacology (2005) [Pubmed]
  15. Cirrhotic cardiomyopathy: an endocannabinoid connection?. Pacher, P., Bátkai, S., Kunos, G. Br. J. Pharmacol. (2005) [Pubmed]
  16. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Pacher, P., Szabó, C. Antioxid. Redox Signal. (2005) [Pubmed]
  17. Cardiovascular pharmacology of cannabinoids. Pacher, P., Bátkai, S., Kunos, G. Handb. Exp. Pharmacol (2005) [Pubmed]
  18. Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice. Pacher, P., Bátkai, S., Kunos, G. J. Physiol. (Lond.) (2004) [Pubmed]
  19. A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. Pacher, P., Vaslin, A., Benko, R., Mabley, J.G., Liaudet, L., Haskó, G., Marton, A., Bátkai, S., Kollai, M., Szabó, C. J. Pharmacol. Exp. Ther. (2004) [Pubmed]
  20. Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Pacher, P., Mabley, J.G., Liaudet, L., Evgenov, O.V., Marton, A., Haskó, G., Kollai, M., Szabó, C. Am. J. Physiol. Heart Circ. Physiol. (2004) [Pubmed]
WikiGenes - Universities